Advertisement

Topics

American Cancer Society and Melanoma Research Alliance Partner to Improve Immunotherapy Outcomes

04:00 EDT 29 Jun 2017 | American Cancer Society

Grants will fund research aimed at decreasing rare but serious side effects associated with checkpoint inhibitors

Original Article: American Cancer Society and Melanoma Research Alliance Partner to Improve Immunotherapy Outcomes

NEXT ARTICLE

More From BioPortfolio on "American Cancer Society and Melanoma Research Alliance Partner to Improve Immunotherapy Outcomes"

Advertisement
Quick Search
Advertisement
Advertisement